CK Group

CK Group is a Hong Kong-based multinational conglomerate founded by Li Ka-shing. It has diverse business interests spanning various sectors, including property development, infrastructure, energy, retail, and biotechnology. The group is currently newsworthy due to activities within its subsidiary, CK Life Sciences, and property transactions involving associated parties. CK Life Sciences is planning to expedite the introduction of its cancer vaccine candidates to mainland China through investigator-initiated trials, leveraging Beijing's push for faster drug development. Separately, properties on Hong Kong's Peak Road, previously acquired from companies linked to CK Group by businessman Chan King-wai, are being offered for sale by public tender, potentially at a loss for the current owner. These events highlight CK Group's ongoing activity in both the biotechnology and property markets, demonstrating its continued relevance in the regional economy.